Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-controlled Trials: The Cross Trial Safety Analysis Scott D. Solomon, MD, Janet Wittes, PhD, Ernest.
© 2010 CV Health: Three Ways to ‘kNOw’ Kathleen O’Neil-Smith, MD Malden, MA.
Powerpoint
Inflammation, Infection and Cardiovascular Disease (
Anaesthesia in Cardiac Patients for Non-cardiac Surgery
Bahan Persentasi Jurnal Reading
Home Environmental Health Hazards: Assessment and Risk Reduction January 13, 2009.
The prevention of Sudden Cardiac Death- Sports & Exercise The prevention of Sudden Cardiac Death- Sports & Exercise ECG Abnormalities in the Athlete Causes.
A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive.
JUPITER Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin Ridker P et al. N Eng J Med 2008;359:
European Guidelines on CVD prevention ESC Commitee für Practice Guidelines to improve the quality of clinical practice and patient care in Europe Fourth.
JUPITER Primary Trial End Point: MI, Stroke, UA/Revascularization, CV Death
